The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis

[1]  B. de Wever,et al.  Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  J. Hovius,et al.  Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  H. Reiber,et al.  Diagnosis of neuroborreliosis – Improved knowledge base for qualified antibody analysis and cerebrospinal fluid data pattern related interpretations , 2013 .

[4]  R. Dessau.  Diagnostic accuracy and comparison of two assays for Borrelia-specific IgG and IgM antibodies: proposals for statistical evaluation methods, cut-off values and standardization. , 2013, Journal of medical microbiology.

[5]  A. Steere,et al.  Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  V. Burgel,et al.  Host-pathogen interactions in Lyme disease and their application in diagnostics , 2013 .

[7]  G. Poggensee,et al.  Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis , 2011, Clinical & developmental immunology.

[8]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[9]  H. Gerritsen,et al.  High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  K. Barrial,et al.  Évaluation des performances de quatre immunoblots commercialisés pour la confirmation de la borréliose de Lyme dans une population de patients suivis en Rhône-Alpes , 2011 .

[11]  J. Ernerudh,et al.  Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. , 2011, The Journal of infection.

[12]  M. Hommes,et al.  Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  R. Dessau,et al.  Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: Survey of patients seen in general practice , 2010, BMC infectious diseases.

[14]  R. Dessau,et al.  Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis: graphical and bivariate analyses , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  F. Strle,et al.  Humoral Immune Responses in Patients with Lyme Neuroborreliosis , 2010, Clinical and Vaccine Immunology.

[16]  Patrick M M Bossuyt,et al.  Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  R. Bennet,et al.  Borrelia Antibodies in Children Evaluated for Lyme Neuroborreliosis , 2008, Infection.

[18]  U. Ljøstad,et al.  RELEVANCE OF THE ANTIBODY INDEX TO DIAGNOSE LYME NEUROBORRELIOSIS AMONG SEROPOSITIVE PATIENTS , 2008, Neurology.

[19]  J. Ernerudh,et al.  Improved Laboratory Diagnostics of Lyme Neuroborreliosis in Children by Detection of Antibodies to New Antigens in Cerebrospinal Fluid , 2008, The Pediatric infectious disease journal.

[20]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  B. Peťko,et al.  Evaluation of recombinant line immunoblot for detection of Lyme disease in Slovakia: comparison with two other immunoassays. , 2008, Vector borne and zoonotic diseases.

[22]  M. Leeflang,et al.  Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. , 2008, Clinical chemistry.

[23]  A. Marangoni,et al.  Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[24]  P. Bossuyt,et al.  Evaluation of diagnostic tests when there is no gold standard. A review of methods. , 2007, Health technology assessment.

[25]  X. Puéchal,et al.  Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[26]  U. Ljøstad,et al.  Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[27]  F. Strle,et al.  Comparison of immunofluorescence assay (IFA) and LIAISON® in patients with different clinical manifestations of Lyme borreliosis , 2006, Wiener klinische Wochenschrift.

[28]  C. Bruggeman,et al.  Comparison of five different immunoassays for the detection of Borrelia burgdorferi IgM and IgG antibodies. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  M. Cinco,et al.  Evaluation of the C6 enzyme-linked immunoadsorbent assay for the serodiagnosis of Lyme borreliosis in north-eastern Italy. , 2006, The new microbiologica.

[30]  E. Ferenczi,et al.  Different B-cell populations are responsible for the peripheral and intrathecal antibody production in neuroborreliosis. , 2005, International immunology.

[31]  V. Fingerle,et al.  Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues , 2005, Journal of Clinical Microbiology.

[32]  Johannes B Reitsma,et al.  Case-control and two-gate designs in diagnostic accuracy studies. , 2005, Clinical chemistry.

[33]  I. Hanovcová,et al.  Diagnosis of Lyme borreliosis using enzyme immunoanalysis. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[34]  E. Storni,et al.  Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. , 2005, Journal of medical microbiology.

[35]  Unn Ljøstad,et al.  Acute peripheral facial palsy in adults , 2005, Journal of Neurology.

[36]  P. Wahlberg,et al.  Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  Barbara J. B. Johnson,et al.  Significant improvement of the recombinant Borrelia IgG immunoblot for serodiagnosis of early neuroborreliosis. , 2004, International Journal of Medical Microbiology.

[38]  J. Ernerudh,et al.  Lyme borreliosis in Sweden – diagnostic performance of five commercial Borrelia serology kits using sera from well‐defined patient groups , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[39]  J. Knottnerus,et al.  Assessment of the accuracy of diagnostic tests: the cross-sectional study. , 2003, Journal of clinical epidemiology.

[40]  Z. Lepsanovic,et al.  Improved serodiagnosis of early Lyme borreliosis: Immunoblot with local Borrelia afzelii strain , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[41]  I. Christova.  Enzyme-Linked Immunosorbent Assay, Immunofluorescent Assay X and Recombinant Immunoblotting in the Serodiagnosis of Early Lyme Borreliosis , 2003, International journal of immunopathology and pharmacology.

[42]  J. Eiros,et al.  Utility of a commercial immunoblot kit (BAG-Borrelia blot) in the diagnosis of the preliminary stages of Lyme disease. , 2003, Diagnostic microbiology and infectious disease.

[43]  H. Saxén,et al.  Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens. , 2003, Journal of medical microbiology.

[44]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[45]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[46]  Stephanie A. Mulherin,et al.  Spectrum Bias or Spectrum Effect? Subgroup Variation in Diagnostic Test Evaluation , 2002, Annals of Internal Medicine.

[47]  F. Strle,et al.  Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans. , 2002, Wiener klinische Wochenschrift.

[48]  K. Hunfeld,et al.  Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease. , 2002, Wiener klinische Wochenschrift.

[49]  H. Saxén,et al.  Recombinant Flagellin A Proteins from Borrelia burgdorferi Sensu Stricto, B.afzelii, and B. garinii in Serodiagnosis of Lyme Borreliosis , 2001, Journal of Clinical Microbiology.

[50]  V. Fingerle,et al.  An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis , 1999, Medical Microbiology and Immunology.

[51]  J. Schellekens,et al.  Clinical evaluation of guidelines and two-test approach for lyme disease. , 1999, Rheumatology.

[52]  P. Bossuyt,et al.  Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.

[53]  A. E. van den Bogaard,et al.  Evaluation of Fifteen Commercially Available Serological Tests for Diagnosis of Lyme Borreliosis , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[54]  A. Joss,et al.  Evidence-Based Diagnosis of Lyme Disease , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[55]  S. Rauer,et al.  Serodiagnosis of neuroborreliosis: Comparison of reliability of three confirmatory assays , 1999, Infection.

[56]  M. Christiansen,et al.  Peptide-Based OspC Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Lyme Borreliosis , 1998, Journal of Clinical Microbiology.

[57]  E. Dayer,et al.  Interpretation of immunoblots for Lyme borreliosis using a semiquantitative approach. , 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[58]  S. Rauer,et al.  Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens ofBorrelia burgdorferi sensu stricto , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[59]  E. Boltshauser,et al.  Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis , 1997, Neurology.

[60]  H. Hofmann,et al.  Lyme borreliosis — Problems of serological diagnosis , 1996, Infection.

[61]  M. Theisen,et al.  Analysis of the human antibody response to outer surface protein C (OspC) of Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii , 1996, Medical Microbiology and Immunology.

[62]  Y. Poinsignon,et al.  Borréliose de Lyme : spécificité du Western blot (expérience nantaise) , 1996 .

[63]  A. Vogt,et al.  Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease , 1995, Journal of clinical microbiology.

[64]  J. Nikoskelainen,et al.  Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis , 1995, Journal of clinical microbiology.

[65]  J. Schellekens,et al.  Serum antibodies to the flagellum of Borrelia burgdorferi measured with an inhibition enzyme-linked immunosorbent assay are diagnostic for Lyme borreliosis , 1994 .

[66]  C. P. V. Boven,et al.  Evaluation of nine serological tests for diagnosis of Lyme borreliosis , 1994, European Journal of Clinical Microbiology and Infectious Diseases.

[67]  A. Hofmann,et al.  Recombinant immunoblot in the serodiagnosis of Lyme borreliosis , 1993, Medical Microbiology and Immmunology.

[68]  B. Dijkmans,et al.  Rational diagnosis and treatment in unclassified arthritis: how clinical data may guide requests for Lyme serology and antibiotic treatment. , 1993, Annals of the rheumatic diseases.

[69]  R. Lange,et al.  [Correlation between neurologic disease and Borrelia burgdorferi antibodies in 800 paired serum/cerebrospinal fluid samples]. , 1992, Der Nervenarzt.

[70]  P. Imbs,et al.  Comparaison de l'immunofluorescence indirecte et du western blot pour le sérodiagnostic des infections neurologiques à Borrelia burgdorferi , 1992 .

[71]  A. Sjöstedt,et al.  Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purifiedBorrelia burgdorferi cell components , 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[72]  H. Hofmann,et al.  [Serodiagnosis in dermatological diseases in Borrelia burgdorferi infections]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[73]  M. Granström,et al.  An IgM-antibody capture enzyme immunoassay for serodiagnosis of Lyme borreliosis , 1989 .

[74]  B. Wretlind,et al.  Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis , 1989, European Journal of Clinical Microbiology and Infectious Diseases.

[75]  K. Hansen,et al.  Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay , 1989, Journal of clinical microbiology.

[76]  N. Pedersen,et al.  Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease , 1988, Journal of clinical microbiology.

[77]  H. Hofstad,et al.  Bannwarth's syndrome: serum and CSF IgG antibodies against Borrelia burgdorferi examined by ELISA , 1987, Acta neurologica Scandinavica.

[78]  Patrick M. M. Bossuyt,et al.  Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy , 2013 .

[79]  C. W. Ang,et al.  Nationale vergelijking van serologische assays voor het aantonen van Borrelia-antistoffen. , 2012 .

[80]  J. Bednářová.  Cerebrospinal-fluid profile in neuroborreliosis and its diagnostic significance , 2008, Folia Microbiologica.

[81]  I. Eliasson,et al.  C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden , 2006, European Journal of Clinical Microbiology & Infectious Diseases.

[82]  E. Storni,et al.  Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. , 2005, The new microbiologica.

[83]  M. Šimkovicová,et al.  Significance of specific antibody determination in Lyme borreliosis diagnosis. , 2001, Bratislavske lekarske listy.

[84]  A. E. van den Bogaard,et al.  Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting. , 2001, Clinical laboratory.

[85]  Van den Bogaard Ae,et al.  Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting. , 2001 .

[86]  F. Noll,et al.  Diagnostische Wertigkeit serologischer Verfahren bei der Diagnostik einer Infektion mit Borrelia burgdorferi. Diagnostic Value of Serological Test-Systems Used in Diagnosis of Infection With Borrelia Burgdorferi , 2000 .

[87]  R. Flisiak,et al.  Western blot banding pattern in early Lyme borreliosis among patients from an endemic region of north-eastern Poland. , 1998, Roczniki Akademii Medycznej w Bialymstoku.

[88]  R. Flisiak,et al.  Enzyme immunoassay in the diagnosis of Lyme borreliosis. , 1996, Roczniki Akademii Medycznej w Bialymstoku.

[89]  B. Luft,et al.  Lyme borreliosis. , 1994, International journal of antimicrobial agents.

[90]  H. Hanson,et al.  Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans. , 1991, Acta dermato-venereologica.

[91]  A. Lebech,et al.  LYME NEUROBORRELIOSIS: A NEW SENSITIVE DIAGNOSTIC ASSAY FOR INTRATHECAL SYNTHESIS OF BORRELIA BURGDORFERI—SPECIFIC IMMUNOGLOBULIN G, A, AND M , 1992 .

[92]  T. Jaenson.  The epidemiology of lyme borreliosis. , 1991, Parasitology today.

[93]  T. Schneider,et al.  Borrelia burgdorferi-Antikörpernachweis Vergleich der Testsysteme IFT, ELISA und Western-Blot , 1991 .